Cat.#: ACPP-1135
| Despition | ACTH Blocking Peptide for Immmunodepletion, Competition Assay |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1469 | Human S100A8 Protein (AC1469) | 5 µg | inquiry |
| ACPP-1552 | Human CDNF Protein (AC1552) | 5 µg | inquiry |
| ACPP-1258 | Pannexin 1 Blocking Peptide (AC1258) | 250 µg | inquiry |
| ACPP-1601 | Rat ACRP30 Protein (AC1601) | 2 µg | inquiry |
| ACPP-1078 | Glutamate Receptor 1 Blocking Peptide (AC1078) | 250 µg | inquiry |
| ACPP-1362 | MERTK Blocking Peptide (AC1362) | 250 µg | inquiry |
| ACPP-1383 | Human KLF7 Protein (AC1383) | 5 µg | inquiry |
| ACPP-1152 | PAX5 Blocking Peptide (AC1152) | 250 µg | inquiry |
| ACPP-1467 | Human SCN3B Protein (AC1467) | 2 µg | inquiry |
| ACPP-1528 | Human RCAN3 Protein (AC1528) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.